This topic contains a solution. Click here to go to the answer

Author Question: It is biochemically impossible to convert carbohydrate to fatty acids. Indicate whether the ... (Read 65 times)

littleanan

  • Hero Member
  • *****
  • Posts: 575
It is biochemically impossible to convert carbohydrate to fatty acids.
  Indicate whether the statement is true or false

Question 2

An RER of 1.0 means that 100 of the fuel used is derived from fat and 0 is derived from carbohydrate.
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Meganchabluk

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

FALSE

Answer to Question 2

FALSE




littleanan

  • Member
  • Posts: 575
Reply 2 on: Aug 21, 2018
Thanks for the timely response, appreciate it


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library